Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FNMTV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,106
Award facts
- Contract value 100% obligated
- $25,106.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $25,106.30 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The award carries an ultimate completion date of June 24, 2025, and does not utilize any set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026, enabling the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare operations globally.
EXPAREL is a liposomal bupivacaine formulation used for surgical site infiltration and nerve blocks to provide extended analgesia following surgical procedures. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group maintains a robust portfolio delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The company's consistent contract awards with the DLA underscore its importance as a preferred vendor for specialized pharmaceutical products supporting the medical supply needs of the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FNMTV?
SPE2DB25FNMTV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FNMTV worth?
The government has obligated $25,106 on SPE2DB25FNMTV.
Is contract SPE2DB25FNMTV an order under another contract?
Yes. SPE2DB25FNMTV is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMTV competed?
The extent of competition for SPE2DB25FNMTV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award